{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:47:28Z","timestamp":1778813248063,"version":"3.51.4"},"reference-count":115,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.pcad.2020.02.009","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T20:08:24Z","timestamp":1581538104000},"page":"233-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Role of endothelial dysfunction in determining angina after percutaneous coronary intervention: Learning from pathophysiology to optimize treatment"],"prefix":"10.1016","volume":"63","author":[{"given":"Fabio","family":"Mangiacapra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco Giuseppe","family":"Del Buono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Gori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco Antonio","family":"Montone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Crea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampaolo","family":"Niccoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.pcad.2020.02.009_bb0005","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pcad.2020.02.009_bb0010","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.pcad.2020.02.009_bb0015","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/CIRCRESAHA.118.311098","article-title":"Reassessing the mechanisms of acute coronary syndromes","volume":"124","author":"Libby","year":"2019","journal-title":"Circ Res"},{"issue":"14","key":"10.1016\/j.pcad.2020.02.009_bb0020","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.118.031373","article-title":"Reappraisal of ischemic heart disease","volume":"138","author":"Kaski","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2020.02.009_bb0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcard.2017.07.105","article-title":"Angina after percutaneous coronary intervention: the need for precision medicine","volume":"248","author":"Niccoli","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2020.02.009_bb0030","doi-asserted-by":"crossref","unstructured":"Pocock SJ, Henderson RA, Clayton T, Lyman GH, Chamberlain DA. Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina. J Am Coll Cardiol 2000 15;35(4):907-14.","DOI":"10.1016\/S0735-1097(99)00637-3"},{"issue":"7","key":"10.1016\/j.pcad.2020.02.009_bb0035","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0735-1097(03)00951-3","article-title":"Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy","volume":"42","author":"Henderson","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.pcad.2020.02.009_bb0040","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJMoa072771","article-title":"Effect of PCI on quality of life in patients with stable coronary disease","volume":"359","author":"Weintraub","year":"2008","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.pcad.2020.02.009_bb0045","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJMoa1001508","article-title":"Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery","volume":"364","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.pcad.2020.02.009_bb0050","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1067\/mhj.2002.125505","article-title":"Registry Investigators. Angina 1 year after percutaneous coronary intervention: a report from the NHLBI Dynamic Registry","volume":"144","author":"Holubkov","year":"2002","journal-title":"Am Heart J"},{"issue":"9","key":"10.1016\/j.pcad.2020.02.009_bb0055","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/eurheartj\/ehl562","article-title":"Recurrent angina after coronary revascularization: a clinical challenge","volume":"28","author":"Abbate","year":"2007","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.pcad.2020.02.009_bb0060","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1177\/2047487318777435","article-title":"Endothelial dysfunction as predictor of angina recurrence after successful percutaneous coronary intervention using second generation drug eluting stents","volume":"25","author":"Montone","year":"2018","journal-title":"Eur J Prev Cardiol"},{"issue":"11","key":"10.1016\/j.pcad.2020.02.009_bb0065","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/oxfordjournals.eurheartj.a060783","article-title":"Predictors of angiographic findings when chest pain recurs after successful coronary angioplasty","volume":"16","author":"Tan","year":"1995","journal-title":"Eur Heart J"},{"issue":"23 Suppl 1","key":"10.1016\/j.pcad.2020.02.009_bb0070","first-page":"III27","article-title":"Role of endothelial dysfunction in atherosclerosis","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pcad.2020.02.009_bb0075","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ijcard.2012.12.001","article-title":"Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis","volume":"168","author":"Yoon","year":"2013","journal-title":"Int J Cardiol"},{"issue":"18","key":"10.1016\/j.pcad.2020.02.009_bb0080","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1136\/hrt.2009.166017","article-title":"Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques","volume":"95","author":"Lavi","year":"2009","journal-title":"Heart."},{"issue":"27","key":"10.1016\/j.pcad.2020.02.009_bb0085","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/eurheartj\/eht132","article-title":"Coronary endothelial dysfunction in patients with early coronary artery disease is associated with the increase in intravascular lipid core plaque","volume":"34","author":"Choi","year":"2013","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.pcad.2020.02.009_bb0090","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1161\/ATVBAHA.114.304445","article-title":"Coronary endothelial dysfunction is associated with inflammation and vasa vasorum proliferation in patients with early atherosclerosis","volume":"34","author":"Choi","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.pcad.2020.02.009_bb0095","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/CIRCULATIONAHA.118.035837","article-title":"Role of postintervention fractional flow reserve to improve procedural and clinical outcomes","volume":"139","author":"Hakeem","year":"2019","journal-title":"Circulation."},{"issue":"15","key":"10.1016\/j.pcad.2020.02.009_bb0100","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jacc.2018.02.023","article-title":"Stent thrombosis, and bleeding complications: navigating between Scylla and Charybdis","volume":"71","author":"Torrado","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"47","key":"10.1016\/j.pcad.2020.02.009_bb0105","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1093\/eurheartj\/ehv511","article-title":"Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gr\u00fcntzig lecture ESC 2014","volume":"36","author":"Byrne","year":"2015","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.pcad.2020.02.009_bb0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/ehjcvp\/pvy036","article-title":"Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge","volume":"5","author":"Borovac","year":"2019","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"4","key":"10.1016\/j.pcad.2020.02.009_bb0115","first-page":"733","article-title":"Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions","volume":"44","author":"Kipshidze","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2020.02.009_bb0120","first-page":"19(12)","article-title":"Endothelial function: a short guide for the interventional cardiologist","author":"Gori","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.pcad.2020.02.009_bb0125","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MCA.0b013e328301ba8e","article-title":"Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events and restenosis in patients undergoing coronary stent implantation: a prospective study","volume":"19","author":"Akcakoyun","year":"2008","journal-title":"Coron Artery Dis"},{"issue":"4","key":"10.1016\/j.pcad.2020.02.009_bb0130","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jacc.2005.04.055","article-title":"Endothelial vasomotor dysfunction in the brachial artery is associated with late in-stent coronary restenosis","volume":"46","author":"Kitta","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2020.02.009_bb0135","doi-asserted-by":"crossref","unstructured":"Patti G, Pasceri V, Melfi R, Goffredo C, Chello M, D'Ambrosio A, Montesanti R, Di Sciascio G. Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation. Circulation 2005;111(1):70\u20135.","DOI":"10.1161\/01.CIR.0000151308.06673.D2"},{"issue":"10","key":"10.1016\/j.pcad.2020.02.009_bb0140","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jcin.2014.05.016","article-title":"Stent thrombosis: a clinical perspective","volume":"7","author":"Claessen","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"26","key":"10.1016\/j.pcad.2020.02.009_bb0145","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1093\/eurheartj\/ehy275","volume":"39","author":"Saito","year":"2018","journal-title":"Eur Heart J."},{"key":"10.1016\/j.pcad.2020.02.009_bb0150","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCULATIONAHA.113.004096","article-title":"Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries","volume":"129","author":"Ong","year":"2014","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.pcad.2020.02.009_bb0155","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.jacc.2009.07.045","article-title":"Role of Rho-kinase in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stents in pigs in vivo","volume":"54","author":"Shiroto","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.pcad.2020.02.009_bb0160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/CIRCINTERVENTIONS.108.797928","article-title":"Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses","volume":"1","author":"Hamilos","year":"2008","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.pcad.2020.02.009_bb0165","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jacc.2005.01.062","article-title":"Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction","volume":"46","author":"Togni","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.pcad.2020.02.009_bb0170","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jcin.2011.05.025","article-title":"Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis","volume":"4","author":"Inoue","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2020.02.009_bb0175","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1161\/01.CIR.84.6.2307","article-title":"Inappropriate constriction of small coronary vessels as a possible cause of a positive exercise test early after successful coronary angioplasty","volume":"84","author":"el-Tamimi","year":"1991","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pcad.2020.02.009_bb0180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00392-013-0615-9","article-title":"Coronary vasomotor abnormalities in patients with stable angina after successful stent implantation but without in-stent restenosis","volume":"103","author":"Ong","year":"2014","journal-title":"Clin Res Cardiol"},{"issue":"7","key":"10.1016\/j.pcad.2020.02.009_bb0185","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jacc.2011.11.015","article-title":"High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries)","volume":"59","author":"Ong","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.pcad.2020.02.009_bb0190","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0735-1097(02)01690-X","article-title":"Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina","volume":"39","author":"Sun","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.pcad.2020.02.009_bb0195","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1161\/hc4501.099316","article-title":"Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but \u201cNormal\u201d coronary angiography","volume":"104","author":"De Bruyne","year":"2001","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.pcad.2020.02.009_bb0200","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.pcad.2014.12.002","article-title":"Regulation of coronary blood flow in health and ischemic heart disease","volume":"57","author":"Duncker","year":"2015","journal-title":"Prog Cardiovasc Dis"},{"issue":"8","key":"10.1016\/j.pcad.2020.02.009_bb0205","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","article-title":"Coronary microvascular dysfunction. Imaging techniques for assessment of coronary flow reserve","volume":"356","author":"Camici","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.pcad.2020.02.009_bb0210","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/0735-1097(95)00327-4","article-title":"Close relation of endothelial function in the human coronary and peripheral circulations","volume":"26","author":"Anderson","year":"1995","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.pcad.2020.02.009_bb0215","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2013.10.038","article-title":"Provocative testing for coronary reactivity and spasm","volume":"63","author":"Zaya","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2020.02.009_bb0220","article-title":"ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"2019","author":"Knuuti","year":"2019","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.pcad.2020.02.009_bb0225","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","article-title":"TIMI frame count: a quantitative method of assessing coronary artery flow","volume":"93","author":"Gibson","year":"1996","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.pcad.2020.02.009_bb0230","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11239-008-0220-3","article-title":"Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15\u00a0years","volume":"27","author":"Kunadian","year":"2009","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.pcad.2020.02.009_bb0235","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1161\/01.CIR.0000080700.98607.D1","article-title":"Novel index for invasively assessing the coronary microcirculation","volume":"107","author":"Fearon","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2020.02.009_bb0240","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jacc.2012.11.025","article-title":"Intracoronary EnalaPrilat to reduce MICROvascular damage during percutaneous coronary intervention (ProMicro) study","volume":"61","author":"Mangiacapra","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.pcad.2020.02.009_bb0245","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.006194","article-title":"Catheter-based measurements of absolute coronary blood flow and microvascular resistance: feasibility, safety, and reproducibility in humans","volume":"11","author":"Xaplanteris","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2020.02.009_bb0250","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jcmg.2014.11.016","article-title":"Regadenoson versus dipyridamole hyperemia for cardiac PET imaging","volume":"8","author":"Johnson","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.pcad.2020.02.009_bb0255","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/hrt.2009.174367","article-title":"Diagnostic value of perfusion cardiovascular magnetic resonance in patients with angina pectoris but normal coronary angiograms assessed by intracoronary acetylcholine testing","volume":"96","author":"Yilmaz","year":"2010","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.pcad.2020.02.009_bb0260","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1161\/01.CIR.91.5.1314","article-title":"Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo","volume":"91","author":"Joannides","year":"1995","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pcad.2020.02.009_bb0265","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force","volume":"39","author":"Corretti","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2020.02.009_bb0270","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/0735-1097(94)90141-4","article-title":"Endothelium-dependent vasodilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction","volume":"24","author":"Celermajer","year":"1994","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.pcad.2020.02.009_bb0275","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/eurheartj\/ehr361","article-title":"Endothelial function assessment: flow-mediated dilation and constriction provide different and complementary information on the presence of coronary artery disease","volume":"33","author":"Gori","year":"2012","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.pcad.2020.02.009_bb0280","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.jacc.2008.01.049","article-title":"Conduit artery constriction mediated by low flow a novel noninvasive method for the assessment of vascular function","volume":"51","author":"Gori","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.pcad.2020.02.009_bb0285","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/eurheartj\/ehq010","article-title":"Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events","volume":"31","author":"Rubinshtein","year":"2010","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.pcad.2020.02.009_bb0290","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/HYPERTENSIONAHA.110.160812","article-title":"Relation of brachial and digital measures of vascular function in the community: the Framingham heart study","volume":"57","author":"Hamburg","year":"2011","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.pcad.2020.02.009_bb0295","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.109.864801","article-title":"Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis","volume":"120","author":"Yeboah","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pcad.2020.02.009_bb0300","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.110.953653","article-title":"Microvascular function predicts cardiovascular events in primary prevention: long-term results from the firefighters and their endothelium (FATE) study","volume":"123","author":"Anderson","year":"2011","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.pcad.2020.02.009_bb0305","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/CIRCULATIONAHA.110.984047","article-title":"Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease","volume":"123","author":"Lind","year":"2011","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pcad.2020.02.009_bb0310","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/CIRCULATIONAHA.112.093245","article-title":"The assessment of endothelial function: from research into clinical practice","volume":"126","author":"Flammer","year":"2012","journal-title":"Circulation."},{"issue":"11","key":"10.1016\/j.pcad.2020.02.009_bb0315","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/01.CIR.0000121360.31954.1F","article-title":"Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial","volume":"109","author":"Hambrecht","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2020.02.009_bb0320","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijcard.2016.12.145","article-title":"Effect of exercise training on endothelial function in heart failure patients: a systematic review meta-analysis","volume":"231","author":"Pearson","year":"2017","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.pcad.2020.02.009_bb0325","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1177\/1741826711415679","article-title":"Effect of exercise training on vascular endothelial function in patients with stable coronary artery disease: a randomized controlled trial","volume":"19","author":"Luk","year":"2012","journal-title":"Eur J Prev Cardiol"},{"issue":"12","key":"10.1016\/j.pcad.2020.02.009_bb0330","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/CIRCULATIONAHA.108.821736","article-title":"Effects of different types of exercise training followed by detraining on endothelium-dependent dilation in patients with recent myocardial infarction","volume":"119","author":"Vona","year":"2009","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.pcad.2020.02.009_bb0335","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1381\/0960892054621134","article-title":"Endothelial function and weight loss in obese humans","volume":"15","author":"Williams","year":"2005","journal-title":"Obes Surg"},{"issue":"18","key":"10.1016\/j.pcad.2020.02.009_bb0340","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.jacc.2010.03.002","article-title":"Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial","volume":"55","author":"Johnson","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.pcad.2020.02.009_bb0345","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jama.292.12.1440","article-title":"Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial","volume":"292","author":"Esposito","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2020.02.009_bb0350","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fcvm.2017.00064","article-title":"Role of dietary antioxidants in the preservation of vascular function and the modulation of health and disease","volume":"4","author":"Varadharaj","year":"2017","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.pcad.2020.02.009_bb0355","doi-asserted-by":"crossref","unstructured":"Tzemos N, Lim PO, MacDonald TM. Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study. Circulation 2001l 31;104(5):511\u20134.","DOI":"10.1161\/hc3001.094207"},{"key":"10.1016\/j.pcad.2020.02.009_bb0360","doi-asserted-by":"crossref","unstructured":"Feuerstein GZ, Ruffolo RR Jr. Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection. Eur Heart J 1995;16 Suppl F:38\u201342.","DOI":"10.1093\/eurheartj\/16.suppl_F.38"},{"issue":"5","key":"10.1016\/j.pcad.2020.02.009_bb0365","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1067\/mhj.2000.110093","article-title":"Carvedilol improves endothelium-dependent dilatation in patients with coronary artery disease","volume":"140","author":"Matsuda","year":"2000","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.pcad.2020.02.009_bb0370","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.amjhyper.2007.01.019","article-title":"Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus","volume":"20","author":"Bank","year":"2007","journal-title":"Am J Hypertens"},{"issue":"3","key":"10.1016\/j.pcad.2020.02.009_bb0375","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/01.HYP.37.3.943","article-title":"Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension","volume":"37","author":"Taddei","year":"2001","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.pcad.2020.02.009_bb0380","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.CIR.0000046488.52939.BF","article-title":"Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of nifedipine and cerivastatin on recovery of coronary endothelial function)","volume":"107","author":"ENCORE Investigators","year":"2003","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.pcad.2020.02.009_bb0385","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/eurheartj\/ehp151","article-title":"Randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study","volume":"30","author":"L\u00fcscher","year":"2009","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.pcad.2020.02.009_bb0390","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0735-1097(99)00537-9","article-title":"Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)","volume":"35","author":"Anderson","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.pcad.2020.02.009_bb0395","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/01.CIR.94.3.258","article-title":"Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study","volume":"94","author":"Mancini","year":"1996","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pcad.2020.02.009_bb0400","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1161\/01.HYP.0000070956.57418.22","article-title":"Different effect of antihypertensive drugs on conduit artery endothelial function","volume":"41","author":"Ghiadoni","year":"2003","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.pcad.2020.02.009_bb0405","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cardiores.2006.10.021","article-title":"ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT","volume":"73","author":"Ceconi","year":"2007","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.pcad.2020.02.009_bb0410","article-title":"Angiotensin II receptor blockers improve peripheral endothelial function: a meta-analysis of randomized controlled trials","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.pcad.2020.02.009_bb0415","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/clc.4960271020","article-title":"Should standard medical therapy for angina include a statin?","volume":"27","author":"Corti","year":"2004","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.pcad.2020.02.009_bb0420","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"10","key":"10.1016\/j.pcad.2020.02.009_bb0425","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/eurheartj\/ehi881","article-title":"Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for \u201cpleiotropic\u201d functions of statin therapy","volume":"27","author":"Fichtlscherer","year":"2006","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.pcad.2020.02.009_bb0430","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1161\/01.CIR.95.5.1126","article-title":"Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month","volume":"95","author":"O\u2019Driscoll","year":"1997","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.pcad.2020.02.009_bb0435","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1110874","article-title":"Effect of two intensive statin regimens on progression of coronary disease","volume":"365","author":"Nicholls","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.pcad.2020.02.009_bb0440","doi-asserted-by":"crossref","first-page":"H1425","DOI":"10.1152\/ajpheart.00783.2003","article-title":"ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles","volume":"286","author":"Tiefenbacher","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"10.1016\/j.pcad.2020.02.009_bb0445","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/HYPERTENSIONAHA.112.203661","article-title":"Fenofibrate improves vascular endothelial function by reducing oxidative stress while increasing endothelial nitric oxide synthase in healthy normolipidemic older adults","volume":"60","author":"Walker","year":"2012","journal-title":"Hypertension"},{"issue":"15","key":"10.1016\/j.pcad.2020.02.009_bb0450","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1161\/01.CIR.101.15.1773","article-title":"Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus","volume":"101","author":"Evans","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2020.02.009_bb0455","doi-asserted-by":"crossref","unstructured":"Moertl D, Hammer A, Steiner S, Hutuleac R, Vonbank K, Berger R. Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-controlled, 3-arm study. Am Heart J 2011;161(5):915.e1\u20139.","DOI":"10.1016\/j.ahj.2011.02.011"},{"issue":"2","key":"10.1016\/j.pcad.2020.02.009_bb0460","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.atherosclerosis.2012.01.006","article-title":"Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials","volume":"221","author":"Wang","year":"2012","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.pcad.2020.02.009_bb0465","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.pcad.2020.02.009_bb0470","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.CIR.0000048143.25023.87","article-title":"Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial","volume":"107","author":"Borer","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pcad.2020.02.009_bb0475","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00392-016-1024-7","article-title":"Heart rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study","volume":"106","author":"Mangiacapra","year":"2017","journal-title":"Clin Res Cardiol"},{"issue":"12","key":"10.1016\/j.pcad.2020.02.009_bb0480","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa1406430","article-title":"Ivabradine in stable coronary artery disease without clinical heart failure","volume":"371","author":"Fox","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.pcad.2020.02.009_bb0485","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/MCA.0000000000000272","article-title":"Influence of trimetazidine and ranolazine on endothelial function in patients with ischemic heart disease","volume":"26","author":"Rehberger-Likozar","year":"2015","journal-title":"Coron Artery Dis"},{"issue":"9","key":"10.1016\/j.pcad.2020.02.009_bb0490","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1185\/030079904X2637","article-title":"Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study","volume":"20","author":"Ruzyllo","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.pcad.2020.02.009_bb0495","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.atherosclerosis.2015.03.045","article-title":"Long-term effect of molsidomine, a direct nitric oxide donor, as an add-on treatment, on endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: results of the MEDCOR trial","volume":"240","author":"Barbato","year":"2015","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.pcad.2020.02.009_bb0500","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.pcad.2020.02.009_bb0505","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (efficacy of ranolazine in chronic angina) trial","volume":"48","author":"Stone","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.pcad.2020.02.009_bb0510","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jacc.2009.01.037","article-title":"Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (metabolic efficiency with ranolazine for less ischemia in non-ST-segment elevation acute coronary syndromes) 36 trial","volume":"53","author":"Wilson","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.pcad.2020.02.009_bb0515","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCOUTCOMES.108.798009","article-title":"Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial","volume":"1","author":"Arnold","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"5","key":"10.1016\/j.pcad.2020.02.009_bb0520","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/MCA.0b013e32832a198b","article-title":"Ranolazine improves endothelial function in patients with stable coronary artery disease","volume":"20","author":"Deshmukh","year":"2009","journal-title":"Coron Artery Dis"},{"issue":"10014","key":"10.1016\/j.pcad.2020.02.009_bb0525","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0140-6736(15)00459-6","article-title":"Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Weisz","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pcad.2020.02.009_bb0530","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.115.019768","article-title":"Effects of ranolazine on angina and quality of life after percutaneous coronary intervention with incomplete revascularization: results from the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) trial","volume":"133","author":"Alexander","year":"2016","journal-title":"Circulation"},{"issue":"9314","key":"10.1016\/j.pcad.2020.02.009_bb0535","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(02)08265-X","article-title":"Effect of nicorandil on coronary events in patients with stable angina: the impact of Nicorandil in Angina (IONA) randomised trial","volume":"359","author":"IONA Study Group","year":"2002","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.pcad.2020.02.009_bb0540","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0195-668X(03)00202-1","article-title":"Evidence of pharmacologic preconditioning during PTCA by intravenous pretreatment with ATP-sensitive K+ channel opener nicorandil","volume":"24","author":"Matsuo","year":"2003","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.pcad.2020.02.009_bb0545","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/FJC.0b013e318163a95f","article-title":"Effects of long-term nicorandil administration on endothelial function, inflammation, and oxidative stress in patients without coronary artery disease","volume":"51","author":"Ishibashi","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"issue":"11","key":"10.1016\/j.pcad.2020.02.009_bb0550","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1161\/CIRCULATIONAHA.116.023743","article-title":"Clopidogrel versus Ticagrelor for antiplatelet maintenance in diabetic patients treated with percutaneous coronary intervention: results of the CLOTILDIA study (clopidogrel high dose versus ticagrelor for antiplatelet maintenance in diabetic patients)","volume":"134","author":"Mangiacapra","year":"2016","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pcad.2020.02.009_bb0555","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1160\/TH16-12-0973","article-title":"Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease","volume":"117","author":"Campo","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pcad.2020.02.009_bb0560","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1908077","article-title":"Ticagrelor in patients with stable coronary disease and diabetes","author":"Steg","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2020.02.009_bb0565","doi-asserted-by":"crossref","unstructured":"Ford TJ, Stanley B, Good R, Rocchiccioli P, McEntegart M, Watkins S, Eteiba H, Shaukat A, Lindsay M, Robertson K, Hood S, McGeoch R, McDade R, Yii E, Sidik N, McCartney P, Corcoran D, Collison D, Rush C, McConnachie A, Touyz RM, Oldroyd KG, Berry C. Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial. J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2841\u20132855. doi: https:\/\/doi.org\/10.1016\/j.jacc.2018.09.006. [Epub 2018 Sep 25].","DOI":"10.1016\/j.jacc.2018.09.006"},{"issue":"7","key":"10.1016\/j.pcad.2020.02.009_bb0570","first-page":"1017","article-title":"Angina and associated healthcare costs following percutaneous coronary intervention: a real-world analysis from a multi-payer database","volume":"88","author":"Ben-Yehuda","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.pcad.2020.02.009_bb0575","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.pcad.2014.10.004","article-title":"Treating coronary disease and the impact of endothelial dysfunction","volume":"57","author":"Matsuzawa","year":"2015","journal-title":"Prog Cardiovasc Dis"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062020300396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062020300396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:16:50Z","timestamp":1758500210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062020300396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":115,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0033062020300396"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2020.02.009","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of endothelial dysfunction in determining angina after percutaneous coronary intervention: Learning from pathophysiology to optimize treatment","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2020.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}